Reports on the treatment of patients with systemic lupus erythematosus (SLE) have emphasised therapy for serious, often life-threatening disease.' 2 The management of mild or inactive cases is not usually discussed. Subsets of patients with SLE have been identified who require little or no therapy, for example, those cases which are serologically active but clinically quiescent.3 Recognition of the complications of therapy4 5 has prompted a constant effort to keep drug therapy at a minimum and wherever possible to discontinue it altogether. We describe 4 patients from a total population of 160 SLE patients followed up in a university referral centre during the first 5 years of a prospective study who are in complete remission, on no suppressive treatment for a prolonged time.
Materials and methods
Between July 1970 and January 1980, 250 SLE patients were prospectively followed up in the Lupus Clinic at the Wellesley Hospital. The records of the first 160 patients followed up 13 For all of these reasons it would seem advisable to taper and discontinue therapy in all SLE patients in remission. Furthermore, because there are no known clinical or laboratory features to predict those patients whose disease will remit and remain inactive, these patients must continue to be assessed at regular intervals. 
